An ergot preparation (Hydergine) for relief of symptoms of cerebrovascular insufficiency.
作者信息
Banen D M
出版信息
J Am Geriatr Soc. 1972 Jan;20(1):22-4. doi: 10.1111/j.1532-5415.1972.tb01196.x.
Abstract
摘要
相似文献
1
An ergot preparation (Hydergine) for relief of symptoms of cerebrovascular insufficiency.
J Am Geriatr Soc. 1972 Jan;20(1):22-4. doi: 10.1111/j.1532-5415.1972.tb01196.x.
2
Use of an ergot preparation (hydergine) in the convalescent phase of stroke.
J Am Geriatr Soc. 1973 Jan;21(1):10-7. doi: 10.1111/j.1532-5415.1973.tb00841.x.
3
An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
J Am Geriatr Soc. 1972 Aug;20(8):407-12. doi: 10.1111/j.1532-5415.1972.tb01645.x.
4
Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
Med Lett Drugs Ther. 1970 Mar 20;12(6):27-8.
5
An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.
J Am Geriatr Soc. 1971 Mar;19(3):208-17. doi: 10.1111/j.1532-5415.1971.tb02623.x.
6
An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
J Am Geriatr Soc. 1973 Feb;21(2):63-71. doi: 10.1111/j.1532-5415.1973.tb01220.x.
7
Symptomatic treatment of cerebrovascular insufficiency with hydergine.
Curr Ther Res Clin Exp. 1969 Sep;11(9):539-46.
8
[Letter: Double blind study of hydergine in aged patients].
Nouv Presse Med. 1975 Oct 18;4(35):2529.
9
[Hydergine in the symptomatic treatment of cerebrovascular insufficiency. Comparative clinical test with a placebo].
Hospital (Rio J). 1970 Jun;77(6):1907-31.
10
A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
Johns Hopkins Med J. 1972 May;130(5):317-24.
引用本文的文献
1
Hydergine for dementia.
Cochrane Database Syst Rev. 2000;2000(2):CD000359. doi: 10.1002/14651858.CD000359.
2
Advances in the pharmacotherapy of Alzheimer's disease.
Eur Arch Psychiatry Clin Neurosci. 1994;244(5):261-71. doi: 10.1007/BF02190379.
3
Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry.
Psychopharmacology (Berl). 1992;109(1-2):30-40. doi: 10.1007/BF02245477.
Zotero 插件